What Is Targeted Therapy for Lung Cancer?

Targeted therapy is a modern and promising treatment option for lung cancer Singapore patients, particularly those with specific genetic mutations that drive cancer growth. Unlike traditional chemotherapy, which attacks all rapidly dividing cells, targeted therapy uses drugs designed to identify and interfere with the unique molecules involved in cancer progression, offering a more focused and often less toxic approach.

How Targeted Therapy Works

Targeted cancer treatments focus on the biological pathways that are altered in cancer cells. These drugs block signals involved in tumor growth, survival, and spread by interacting with specific proteins, genes, or the blood supply that tumors need to thrive. For example, some medications inhibit mutations in the EGFR or ALK genes, which are commonly found in non-small cell lung cancer among Asians, including many Singapore patients.

Advantages of Targeted Therapy

  • Precision: Targets only cancer cells with specific mutations, sparing most normal cells.
  • Fewer side effects: Compared with chemotherapy, targeted therapy generally causes less hair loss, nausea, and bone marrow suppression.
  • Oral administration: Many targeted drugs are pills taken at home, improving convenience and quality of life.
  • Effectiveness: Particularly beneficial in cancers that have developed resistance to chemotherapy or in advanced stages.

Common Targeted Drugs for Lung Cancer

  • EGFR inhibitors: Gefitinib, erlotinib, and osimertinib block the epidermal growth factor receptor mutations commonly seen in lung cancer.
  • ALK inhibitors: Crizotinib and alectinib target ALK gene rearrangements.
  • Other targets include ROS1, BRAF, and MET, among others—each with specific drugs available in Singapore treatment centers.

Role in Lung Cancer Treatment Options Singapore

Targeted therapy is typically used:

  • For patients with advanced or metastatic non-small cell lung cancer (NSCLC).
  • Following genetic testing that identifies actionable mutations.
  • Sometimes along with chemotherapy, immunotherapy, or after surgery and radiation for better outcomes.

Singapore’s National Cancer Centre (NCCS) and specialized lung cancer clinics utilize advanced molecular profiling to guide personalized therapy plans, a pioneering effort improving survival and life quality for Asian lung cancer patients.

Challenges and Outlook

While targeted therapy offers hope, patients may develop drug resistance over time, leading to relapse. Researchers in Singapore are actively developing new drugs and combination strategies to overcome resistance and prolong patient survival.

Targeted therapy represents a significant advancement in precision cancer therapy and offers new hope for lung cancer patients in Singapore. By treating cancer at its molecular roots, these therapies provide tailored options that often increase effectiveness while minimizing side effects. If you or a loved one is diagnosed with lung cancer, discuss targeted therapy and molecular testing with your oncologist to explore the most suitable treatment options available in Singapore.

 

Disclaimer: The content for this article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your oncologist with any questions regarding a medical condition. Do not disregard medical advice or delay seeking it based on information from this site.

You must be logged in to post a comment.